Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Vivo Metabolic Profiling of Equisetum debile Roxb. in Rats Based on High-Resolution Mass Spectrometry.

Biomedical chromatography : BMC·2026
Same author

Discussions on the generalization of HybridSP on more equivalent benchmarks.

Briefings in bioinformatics·2026
Same author

Nontargeted screening of carbonyl-containing hormonal residues in meat products for food safety by using intelligent high-resolution mass spectrometry-based workflow.

Food chemistry·2026
Same author

Unveiling the Activation Mechanism of Glucagon-Like Peptide-1 Receptor by an Ago-Allosteric Modulator via Molecular Dynamics Simulations.

Journal of chemical information and modeling·2026
Same author

zERExtractor: An Automated Platform for Enzyme-Catalyzed Reaction Data Extraction from Scientific Literature.

Journal of chemical information and modeling·2026
Same author

Corrigendum to "Multi-dimensional PK-PD insights into Lianhua Qingwen's formula compatibility" [J. Ethnopharmacol. 353 (2025) 120251].

Journal of ethnopharmacology·2026

Related Experiment Video

Updated: Aug 26, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K

Cholesterol-stabilized membrane-active nanopores with anticancer activities.

Jie Shen1,2, Yongting Gu1, Lingjie Ke1

  • 1Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, 361102, China.

Nature Communications
|October 10, 2022
PubMed
Summary

Researchers developed artificial cholesterol-dependent nanopores that target cancer cells. These novel nanopores show potent anticancer activity against hepatocellular carcinomas while sparing healthy cells, offering a promising new therapeutic strategy.

More Related Videos

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.0K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.6K

Related Experiment Videos

Last Updated: Aug 26, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.0K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.6K

Area of Science:

  • Biochemistry
  • Nanotechnology
  • Molecular Biology

Background:

  • Cholesterol-free bacteria use pore formation to target cholesterol-rich eukaryotic cells.
  • This mechanism allows bacteria to escape host cell toxicity.
  • Understanding this interaction is key to developing targeted therapies.

Purpose of the Study:

  • To design and characterize artificial cholesterol-dependent nanopores.
  • To investigate the tunable properties of these synthetic nanopores.
  • To evaluate their potential as targeted anticancer agents.

Main Methods:

  • Synthesis of modular amphiphilic molecular backbones for nanopore creation.
  • Characterization of nanopore formation sensitivity to cholesterol concentration (up to 50 mol%).
  • Assessment of pore size, channel activity, and molecular transport capabilities (e.g., 5(6)-carboxyfluorescein).

Main Results:

  • Developed artificial nanopores sensitive to cholesterol concentration.
  • Achieved tunable pore size with a ~1.6 nm cavity diameter in the Ch-C1 channel.
  • Demonstrated potent and selective anticancer activity against human hepatocellular carcinomas (IC50 = 3.8 µM).
  • Exhibited high selectivity indices against normal liver (12.5) and kidney (>130) cells.

Conclusions:

  • Artificial cholesterol-dependent nanopores can be engineered for targeted delivery.
  • These nanopores exhibit significant anticancer efficacy and selectivity.
  • The findings suggest a novel therapeutic avenue for hepatocellular carcinoma treatment.